{"id":8183,"date":"2017-06-21T07:26:41","date_gmt":"2017-06-21T05:26:41","guid":{"rendered":"https:\/\/staging.ggba.swiss\/a-geneve-google-sassocie-a-medicxi-investit-biotech\/"},"modified":"2023-07-04T13:43:03","modified_gmt":"2023-07-04T11:43:03","slug":"a-geneve-google-sassocie-a-medicxi-investit-biotech","status":"publish","type":"post","link":"https:\/\/staging.ggba.swiss\/fr\/a-geneve-google-sassocie-a-medicxi-investit-biotech\/","title":{"rendered":"A Gen\u00e8ve, Google s\u2019associe \u00e0 Medicxi et investit dans le biotech"},"content":{"rendered":"<p>Verily, filiale d\u2019Alphabet, active dans le secteur des sciences de la vie, cherchait depuis un certain temps un partenaire afin de d\u00e9velopper ses activit\u00e9s en Europe. La recherche a touch\u00e9 \u00e0 sa fin et l\u2019entreprise a trouv\u00e9 un partenaire \u00e0 Gen\u00e8ve chez Medicxi, une entreprise de capital-risque vou\u00e9e \u00e0 la biotechnologie issue d\u2019Index Ventures. R\u00e9sultat de ce partenariat\u00a0est le lancement de Medicxi Growth 1 (MG1), un nouveau fonds d\u2019investissement dot\u00e9 de 300 millions de dollars.<\/p>\n<p>Trois g\u00e9ants de la pharma contribuent et investissent dans ce fonds\u00a0: Verily, Novartis et le European Investment Fund (EIT). Ce nouveau fonds d\u2019investissement permettra de combler les lacunes dans le financement europ\u00e9en des sciences de la vie afin de soutenir des entreprises sp\u00e9cialis\u00e9es dans le d\u00e9veloppement de m\u00e9dicaments en phase finale qui n\u2019ont pas le financement n\u00e9cessaire pour se d\u00e9velopper ou cr\u00e9er de nouvelles opportunit\u00e9s. Francesco De Rubertis, CEO et cofondateur de Medicxi, explique dans un <a href=\"https:\/\/www.medicxi.com\/news\/medicxi-launches-first-300m-late-stage-life-sciences-fund-medicxi-growth-1-mg1-backed-by-novartis-and-verily\" target=\"_blank\" rel=\"noopener\">communiqu\u00e9<\/a> que \u00ab\u00a0[le] fonds sera enti\u00e8rement tourn\u00e9 vers les biotech late stage, le premier du genre en Europe par un VC\u00a0\u00bb. L\u2019objectif\u00a0\u00e9tant d\u2019investir dans les entreprises qui ont d\u00e9j\u00e0 atteint la deuxi\u00e8me phase de leurs essais cliniques.<\/p>\n<p><strong>En Suisse, le biotech prend de l\u2019ampleur <\/strong><\/p>\n<p>En 2016, les biotechs suisses se sont class\u00e9es en deuxi\u00e8me position en ce qui concerne la collecte de fonds, selon un <a href=\"http:\/\/www.ey.com\/ch\/en\/newsroom\/news-releases\/news-release-ey-global-biotech-industry-slowed-down-in-2016-but-stays-the-course\" target=\"_blank\" rel=\"noopener\">rapport<\/a> du consultant Ernst &amp; Young. 2016 a notamment \u00e9t\u00e9 une ann\u00e9e tr\u00e8s positive pour le pays en mati\u00e8re de biotech. La soci\u00e9t\u00e9 ADC Therapeutics a lev\u00e9 plus que toute autre entreprise europ\u00e9enne en capital-risque. L&rsquo;entr\u00e9e au Nasdaq de la soci\u00e9t\u00e9 AC Immune, en septembre 2016, a \u00e9t\u00e9 la plus importante introduction europ\u00e9enne de l&rsquo;ann\u00e9e.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Verily, la filiale d\u2019Alphabet (maison m\u00e8re de Google) d\u00e9di\u00e9e aux sciences de la vie, et Novartis rejoignent Medicxi. Tous les trois se lancent dans un partenariat qui vise \u00e0 faciliter le financement du biotech late stage. Il s\u2019agit du premier fond d\u2019investissement de ce type g\u00e9r\u00e9 par un VC en Europe.<\/p>\n","protected":false},"author":3,"featured_media":8184,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"mc4wp_mailchimp_campaign":[]},"categories":[842],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.10 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>A Gen\u00e8ve, Google s\u2019associe \u00e0 Medicxi et investit dans le biotech - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A Gen\u00e8ve, Google s\u2019associe \u00e0 Medicxi et investit dans le biotech - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"Verily, la filiale d\u2019Alphabet (maison m\u00e8re de Google) d\u00e9di\u00e9e aux sciences de la vie, et Novartis rejoignent Medicxi. Tous les trois se lancent dans un partenariat qui vise \u00e0 faciliter le financement du biotech late stage. Il s\u2019agit du premier fond d\u2019investissement de ce type g\u00e9r\u00e9 par un VC en Europe.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staging.ggba.swiss\/fr\/a-geneve-google-sassocie-a-medicxi-investit-biotech\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2017-06-21T05:26:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:43:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Biotech_analyse-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1500\" \/>\n\t<meta property=\"og:image:height\" content=\"1000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/staging.ggba.swiss\/fr\/a-geneve-google-sassocie-a-medicxi-investit-biotech\/\",\"url\":\"https:\/\/staging.ggba.swiss\/fr\/a-geneve-google-sassocie-a-medicxi-investit-biotech\/\",\"name\":\"A Gen\u00e8ve, Google s\u2019associe \u00e0 Medicxi et investit dans le biotech - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"datePublished\":\"2017-06-21T05:26:41+00:00\",\"dateModified\":\"2023-07-04T11:43:03+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/8e5f085a3c4b5b152358afca41905511\"},\"breadcrumb\":{\"@id\":\"https:\/\/staging.ggba.swiss\/fr\/a-geneve-google-sassocie-a-medicxi-investit-biotech\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/staging.ggba.swiss\/fr\/a-geneve-google-sassocie-a-medicxi-investit-biotech\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/staging.ggba.swiss\/fr\/a-geneve-google-sassocie-a-medicxi-investit-biotech\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/staging.ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A Gen\u00e8ve, Google s\u2019associe \u00e0 Medicxi et investit dans le biotech\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/8e5f085a3c4b5b152358afca41905511\",\"name\":\"mathieu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/066e0c4bb04d41ae36e3347b25b925cc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/066e0c4bb04d41ae36e3347b25b925cc?s=96&d=mm&r=g\",\"caption\":\"mathieu\"},\"url\":\"https:\/\/staging.ggba.swiss\/fr\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A Gen\u00e8ve, Google s\u2019associe \u00e0 Medicxi et investit dans le biotech - Greater Geneva Bern area","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"A Gen\u00e8ve, Google s\u2019associe \u00e0 Medicxi et investit dans le biotech - Greater Geneva Bern area","og_description":"Verily, la filiale d\u2019Alphabet (maison m\u00e8re de Google) d\u00e9di\u00e9e aux sciences de la vie, et Novartis rejoignent Medicxi. Tous les trois se lancent dans un partenariat qui vise \u00e0 faciliter le financement du biotech late stage. Il s\u2019agit du premier fond d\u2019investissement de ce type g\u00e9r\u00e9 par un VC en Europe.","og_url":"https:\/\/staging.ggba.swiss\/fr\/a-geneve-google-sassocie-a-medicxi-investit-biotech\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2017-06-21T05:26:41+00:00","article_modified_time":"2023-07-04T11:43:03+00:00","og_image":[{"width":1500,"height":1000,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Biotech_analyse-2.jpg","type":"image\/jpeg"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"Written by":"mathieu","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/staging.ggba.swiss\/fr\/a-geneve-google-sassocie-a-medicxi-investit-biotech\/","url":"https:\/\/staging.ggba.swiss\/fr\/a-geneve-google-sassocie-a-medicxi-investit-biotech\/","name":"A Gen\u00e8ve, Google s\u2019associe \u00e0 Medicxi et investit dans le biotech - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"datePublished":"2017-06-21T05:26:41+00:00","dateModified":"2023-07-04T11:43:03+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/8e5f085a3c4b5b152358afca41905511"},"breadcrumb":{"@id":"https:\/\/staging.ggba.swiss\/fr\/a-geneve-google-sassocie-a-medicxi-investit-biotech\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staging.ggba.swiss\/fr\/a-geneve-google-sassocie-a-medicxi-investit-biotech\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/staging.ggba.swiss\/fr\/a-geneve-google-sassocie-a-medicxi-investit-biotech\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/staging.ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"A Gen\u00e8ve, Google s\u2019associe \u00e0 Medicxi et investit dans le biotech"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/8e5f085a3c4b5b152358afca41905511","name":"mathieu","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/066e0c4bb04d41ae36e3347b25b925cc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/066e0c4bb04d41ae36e3347b25b925cc?s=96&d=mm&r=g","caption":"mathieu"},"url":"https:\/\/staging.ggba.swiss\/fr\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/staging.ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/8183"}],"collection":[{"href":"https:\/\/staging.ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging.ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging.ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/staging.ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=8183"}],"version-history":[{"count":1,"href":"https:\/\/staging.ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/8183\/revisions"}],"predecessor-version":[{"id":17531,"href":"https:\/\/staging.ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/8183\/revisions\/17531"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/staging.ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/8184"}],"wp:attachment":[{"href":"https:\/\/staging.ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=8183"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging.ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=8183"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging.ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=8183"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}